fluorodeoxyglucose f18 has been researched along with Cancer, Second Primary in 143 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (3.50) | 18.2507 |
| 2000's | 49 (34.27) | 29.6817 |
| 2010's | 65 (45.45) | 24.3611 |
| 2020's | 24 (16.78) | 2.80 |
| Authors | Studies |
|---|---|
| Grünig, H; Holzmann, D; Huellner, MW; Husmann, L; Mader, CE; Maurer, A; Meerwein, CM; Messerli, M; Mühlematter, UJ; Rupp, NJ; Skawran, S; Soyka, MB | 1 |
| Dalal, I; Griffith, B; Patel, PY | 1 |
| Annovazzi, A; Carpano, S; Ferraresi, V; Rea, S; Renna, D; Russillo, M; Sciuto, R | 1 |
| He, L; Jiang, L; Ren, J; Tan, X; Zeng, B | 1 |
| Bakker, AS; Haj Mohammad, N; Jairam, J; Kroese, TE; Meijer, GJ; Mook, S; Ruurda, JP; van der Horst, S; van Hillegersberg, R; van Rossum, PSN | 1 |
| Hadzhiyska, V; Ilcheva, M; Mladenov, K; Nikolova, P | 1 |
| Lan, X; Li, M; Zhang, X | 1 |
| Li, L; Li, Y; Xiao, L | 1 |
| Binkovitz, LA; Broski, SM; Guo, RR; Huls, SJ | 1 |
| Baron-Hay, S; Batty, K; Bernard, EJ; Boyle, F; Chan, DL; Clarke, SJ; Diakos, CI; Guminski, A; Pavlakis, N; Taylor, AM | 1 |
| Guan, M; Huang, J; Liu, W; Wei, L; Xie, P | 1 |
| Dong, Z; Guo, Z; Liu, W; Xie, P; Yang, L | 1 |
| Dimitriou, F; Ensle, F; Huellner, MW; Maurer, A; Schaab, JA | 1 |
| Basu, S; Chalikandy, A; Yadav, S | 1 |
| Cesmecioglu, E; Dede, F; Karaman, D; Kesim, S; Turoglu, HT | 1 |
| Aziz, A; Bhosale, P; Frumovitz, M; Gonzales, NR; Jhingran, A; Morani, AC; Ramalingam, P; Salvo, G; Sun, J | 1 |
| Aikata, H; Akagi, M; Awai, K; Chayama, K; Fujino, H; Hiramatsu, A; Imamura, M; Kawaoka, T; Kobayashi, T; Kodama, K; Morio, K; Murakami, E; Nakahara, T; Nakamura, Y; Namba, M; Ohdan, H; Ohya, K; Tsuge, M; Uchikawa, S; Yamauchi, M | 1 |
| Appaduray, SP; Chan, J; Khoo, J; Somasundaram, N; Yan, SX | 1 |
| Clements, W; Haydon, A; Mar, V; McLean, C; Moore, M; Nguyen, J; Shackleton, M; Yap, KS | 1 |
| Basler, L; Bogowicz, M; Dummer, R; Förster, R; Gabryś, HS; Guckenberger, M; Hogan, SA; Huellner, MW; Kudura, K; Levesque, MP; Pavic, M; Tanadini-Lang, S; Vuong, D | 1 |
| Autore, F; Fresa, A; Innocenti, I; Laurenti, L; Paolini, A; Sica, S; Sora, F; Zini, G | 1 |
| Akboru, MH; Atci, M; Cihan, S; Karyagar, S; Karyagar, SS; Sahin, S; Sakin, A | 1 |
| Broglie, MA; Hüllner, MW; Morand, GB; Rupp, NJ; Stadler, TM | 1 |
| Cárdenas-Perilla, R | 1 |
| Cook, G; Goh, V; Kelly-Morland, C; Mallett, S; Montana, G; Nathan, P; Rudman, S | 1 |
| Asano, Y; Fujita, H; Kadono, T; Masui, Y; Miyagawa, T; Saigusa, R; Sato, S; Yamada, D | 1 |
| Berwouts, D; De Gersem, W; De Kerf, G; De Neve, W; De Ost, B; Duprez, F; Goethals, I; Olteanu, AML; Rottey, S; Schatteman, J; Van Gestel, D; Vercauteren, T | 1 |
| Bissoli, S; Fantin, A; Moletta, L; Passuello, N; Sperti, C; Valmasoni, M | 1 |
| Hayakawa, M; Oda, K | 1 |
| Dimitrakopoulou-Strauss, A; Hakim-Meibodi, L; Hassel, JC; Kopp-Schneider, A; Sachpekidis, C | 1 |
| Amoreo, CA; Costantini, M; Gallucci, M; Minisola, F; Poeta, ML; Pompeo, V; Sentinelli, S; Simone, G; Tuderti, G; Vallati, G | 1 |
| Cheng, Z; Song, S; Zhu, X; Zou, S | 1 |
| Ahn, YC; Choi, JY; Hyun, SH; Kim, SJ; Lee, KS; Moon, SH; Oh, D; Shim, YM; Sun, JM; Zo, JI | 1 |
| Bosco, A; Dhiantravan, N; Hovey, E; Wegner, EA | 1 |
| Jeon, YK; Kim, BH; Kim, IJ; Kim, SJ; Kim, SS; Kim, YK; Lee, CH | 1 |
| Dunsky, KA; Osman, MM; Thornberry, BM; Varvares, MA; Wehrmann, DJ | 1 |
| d'Amico, A; Przeorek, C; Turska-d'Amico, M | 1 |
| Bhethanabhotla, S; Durgapal, P; Gajendra, S; Gogia, A; Gupta, R; Sahoo, MK; Tanwar, P | 1 |
| Khangembam, BC; Kumar, R; Naswa, N; Sahoo, MK; Sharma, P | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, JW; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Bal, C; Dhull, VS; Jain, S; Kumar, R; Sharma, P | 1 |
| Bowen, DA; Call, TG; Conte, MJ; Rabe, KG; Schwager, SM; Slager, SL; Viswanatha, DS; Wiseman, GA; Zent, CS | 1 |
| Choi, JS; Choi, Y; Han, KH; Kang, WJ; Kim, EK; Kwak, JY; Moon, HJ; Yoon, JH; Youk, JH | 1 |
| Altman, JK; Dillehay, GL; Evens, AM; Frankfurt, O; Gentzler, RD; Gordon, LI; Kaminer, L; Mehta, J; Mittal, BB; Petrich, AM; Rademaker, AW; Singhal, S; Variakojis, D; Weitner, BB; Williams, S; Winter, JN | 1 |
| Adams, HL; Jaunoo, SS | 1 |
| Le, BB; Nguyen, BD | 1 |
| Abgral, R; Clodic, C; Gobel, Y; Marianowski, R; Mornet, E; Potard, G; Salaun, PY; Valette, G | 1 |
| Abele, J; Allegretto, M; Bedard, E; Hunt, I; Maquire, C; Patel, A; Perry, T | 1 |
| Garcheva, M; Gocheva, L; Zlatareva, D | 1 |
| Dieckmann, K; Kluge, R; Körholz, D; Mauz-Körholz, C; Vordermark, D | 1 |
| Hattori, A; Matsunaga, T; Oh, S; Suzuki, K; Takamochi, K | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR; Peters, TT; Senft, A; Witte, BI | 1 |
| Choi, JY; Kim, JJ; Lee, JH; Min, BH; Rhee, PL; Tae, CH | 1 |
| Fujiwara, K; Harada, H; Hino, M; Itoh, K; Kikuchi, M; Kishimoto, I; Naito, Y; Shinohara, S; Suehiro, A; Tona, R | 1 |
| Ailianou, A; Giger, R; Karamitopoulou, E; Landis, BN; Nisa, L; Salmina, C | 1 |
| Apel, A; Avigdor, A; Ben-Bassat, I; Dann, EJ; Davidson, T; Kedmi, M; Levi, I; Nagler, A; Polliack, A | 1 |
| Brandi, L; Carbonelli, C; Cavazza, A; Cesario, A; Di Paolo, ML; Gasparini, E; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T; Serra, S; Sgarbi, G; Sverzellati, N | 1 |
| Aide, N; Allouache, N; Dugué, AE; How Kit, N; Joly, F; Lesaunier, F; Sevin, E | 1 |
| Shiau, YC; Tsai, SY; Wang, SY; Wu, YW | 1 |
| Itoh, T; Kanda, T; Kitajima, K; Nibu, K; Otsuki, N; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
| Gariani, J; Martin, SP; Tabouret Viaud, C | 1 |
| Asao, T; Fujii, T; Katoh, T; Kigure, W; Kuwano, H; Morita, H; Suto, T; Tsutsumi, S; Yajima, R | 1 |
| Chin, BB; Oldan, JD | 1 |
| Chi, KK; Kader, I; Leavers, B; Shashinder, S; Sundaresan, P; Wylie, B | 1 |
| Boni, R; Castellucci, P; Coraggio, G; Erba, PA; Galeandro, M; Lazzeri, E; Paiar, F; Pasqualetti, F; Perri, M; Roncali, M; Sollini, M; Versari, A | 1 |
| Alfieri, S; Barbaro, B; Bonomo, L; Coco, C; Di Matteo, M; Gambacorta, MA; Giordano, A; Leccisotti, L; Persiani, R; Poscia, A; Salsano, M; Serra, T; Valentini, V; Vecchio, FM | 1 |
| Charest, M; Derbekyan, V; Hickeson, M; Novales, JA; Singnurkar, A | 1 |
| Mahmood, S; Martinez de Llano, SR | 1 |
| Chan, SC; Chang, JT; Chin, SC; Huang, SF; Ko, SF; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Katz, SC; Shaha, A | 1 |
| Ferhanoğlu, B; Iğdem, A; Iğdem, S; Okkan, S; Unalan, B | 1 |
| Krabbe, CA; Pruim, J; Rödiger, LA; Roodenburg, JL; van der Laan, BF | 1 |
| Agrawal, A; Agrawal, R; Baghel, NS; Nair, N | 1 |
| Brenot-Rossi, I; Chuto, G; Gaudy-Marqueste, C; Grob, JJ; Nicol, I; Richard, MA | 1 |
| Deroose, CM; Himpe, U; Leyn, PD; Vansteenkiste, J; Verbeken, E | 1 |
| Haerle, SK; Hany, TF; Schrank, M; Soyka, JD; Stoeckli, SJ; Strobel, K; Veit-Haibach, P | 1 |
| Fujiwara, H; Kaneda, K; Kizaki, T; Nishimura, T; Sendo, H; Shirakawa, S; Wada, T | 1 |
| Genden, EM; Kao, J; Kostakoglu, L; Mocherla, B; Packer, S; Park, EE; Som, PM; Vu, HL | 1 |
| Haerle, SK; Hany, TF; Sidler, D; Stoeckli, SJ; Strobel, K | 1 |
| Aldridge, BA; Beatty, JS; David, GS; Gucwa, AL; Hughes, MP; Kruse, EJ; Lind, DS; McLoughlin, JM; Vasudeva, VS; Williams, HT | 1 |
| Bissoli, S; Chierichetti, F; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Pietrzykowski, J; Wardyn, KA; Zielonka, TM | 1 |
| Balink, H; de Visscher, JG; Dijkstra, PU; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF | 1 |
| Hyodo, M; Kasahara, N; Koizumi, M; Morishima, K; Sakuma, Y; Sasanuma, H; Sata, N; Shimizu, A; Yasuda, Y | 1 |
| Li, B; Xu, H; Zhai, G; Zhang, M | 1 |
| Fennessy, FM; Souza, FF; van den Abbeele, AD; Yang, Q | 1 |
| Haerle, SK; Hälg, RA; Huber, GF; Schaefer, N; Schrepfer, T; Strobel, K | 1 |
| Bussink, J; de Geus-Oei, LF; Dijkman, BG; Looijen-Salamon, M; Oyen, WJ; Schuurbiers, OC; Snoeren, MM; Timmer-Bonte, JN; van der Heijden, HF; Vriens, D | 1 |
| Aquino, SL; Crowley, D; Feng, Y; Hochberg, EP; Lacasce, AS; Lee, AI; Neuberg, DS; Toomey, C; Van den Abbeele, AD; Zuckerman, DS | 1 |
| Duet, M; Faraggi, M; Hugonnet, F | 1 |
| Hickeson, M; Makis, W; Novales-Diaz, JA | 1 |
| Fujiwara, S; Matsuyama, T; Mori, M; Muroi, K; Nagai, T; Oh, I; Ohmine, K; Ozaki, K; Ozawa, K; Sato, K; Suzuki, T | 1 |
| Hiraga, J; Mizuno, S; Okuda, T; Sakemura, R | 1 |
| Fujii, S; Hamanaka, Y; Hara, T; Hayashida, K; Higashi, T; Konishi, I; Nakamoto, Y; Saga, T; Suga, T; Tatsumi, M; Togashi, K | 1 |
| Chan, SC; Chin, SC; Liao, CT; Lin, CY; Ng, SH; Wai, YY; Wang, HM; Wang, JJ; Yen, TC | 1 |
| Aogi, K; Hara, F; Inoue, T; Kiyoto, S; Ohsumi, S; Takabatake, D; Takahashi, M; Takashima, S | 1 |
| Buriánková, E; Indrák, K; Kubová, Z; Kučerová, L; Melichar, B; Mikula, P; Mysliveček, M; Neoral, C; Papajík, T; Procházka, V; Raida, L; Sedová, Z; Starostka, D; Tichý, M | 1 |
| Bomanji, J; Hashemi, M; Iordanidou, L; Markar, SR; Mitchell, I; Read, S; Stoker, D; Vyas, S; Winslet, M | 1 |
| Kim, SH; Mulligan, ME; Smith, SE | 1 |
| Hakozaki, K; Iida, S; Ishihara, K; Kiriyama, T; Kumita, S; Murakami, R; Tsuchiya, S; Yanagihara, K; Yoshida, T | 1 |
| Fukushima, Y; Kawai, K; Mukasa, A; Ota, T; Saito, N; Uozaki, H | 1 |
| Ambati, C; Lin, M | 1 |
| Butrynski, J; Hornick, JL; Jagannathan, JP; Krajewski, KM; Ramaiya, NH; Shinagare, AB; Zukotynski, KA | 1 |
| Essamet, W; Palazzo, FF; Pauleau, G; Sebag, F; Taïeb, D | 1 |
| Berner, U; Diehl, M; Döbert, N; Grünwald, F; Hamscho, N; Ludwig, R; Menzel, C | 1 |
| Bourguet, P | 1 |
| Aigner, RM; Krippl, P; Samonigg, H; Schwarz, T; Wolf, G | 1 |
| Hain, SF | 1 |
| Broelsch, C; Frilling, A; Kühl, H; Müller, S; Stamatis, G; Tecklenborg, K; Weber, F | 1 |
| Baek, CH; Choi, JY; Kim, BT; Kwon, OJ; Lee, KH; Lee, KS; Park, K; Shim, YM | 1 |
| Brouwer, J; Castelijns, JA; Comans, EF; de Bree, R; Golding, RP; Hoekstra, OS; Leemans, CR; Senft, A | 1 |
| Ciernik, IF; Eyrich, GK; Goerres, GW; Schuknecht, B; Stoeckli, SJ; Wild, D | 1 |
| Bridges, B; Hussain, A | 1 |
| Bénard, F; Langlois, MF; Leboeuf, R | 1 |
| Bosly, A; Graux, C; Krug, B; Nollevaux, MC; Sonet, A; Vander Borght, T | 1 |
| Rankin, SC | 1 |
| Ben-Yehuda, D; Cohen, T; Freund, HR; Klein, M; Krausz, Y; Nissan, A | 1 |
| Alvarez Pérez, RM; Borrego Dorado, I; López Martín, J; Vázquez Albertino, R | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Bucerius, J; Hortling, N; Joe, AY; Palmedo, H | 1 |
| Cho, T; Formby, M; Lee, D; Wood, B | 1 |
| Karantanis, D; Mullan, BP; O'Neill, BP; Peller, PJ; Subramaniam, RM; Wiseman, GA; Witte, RJ | 1 |
| Hisaoka, M; Kakeda, S; Korogi, Y; Nagatani, G; Shiomori, T; Suzuki, H; Udaka, T | 1 |
| Chin, K; Finger, PT; Kurli, M; Reddy, S; Tena, LB | 1 |
| Basu, S; Nair, N; Shet, T | 1 |
| Brepoels, L; De Wever, W; De Wolf-Peeters, C; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Uyttebroeck, A; Vandenberghe, P; Verhoef, G | 2 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yeo, NK | 1 |
| Heldmann, M; Lilien, DL; Reddy, MP; Sangster, GP; Takalkar, AM; Zhang, RD | 1 |
| Fukasawa, I; Hagiwara, S; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
| Baba, M; Igarashi, Y; Kodaira, Y; Konno, A; Miyazaki, M; Nakazawa, T; Sakuma, H; Shishido, F; Takekawa, S; Teranishi, Y; Watanabe, K | 1 |
| Wong, RJ | 1 |
| Göhring, UJ; Pietrzyk, U; Scharl, A; Scheidhauer, K; Schomäcker, K | 1 |
| Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Greven, KM; Keyes, JW; McGuirt, WF; Watson, N; Williams, DW | 1 |
| Bakheet, SM; Bakri, Y; Ezzat, A; Powe, J | 1 |
| Hordijk, GJ; Moons, KG; Stokkel, MP; ten Broek, FW; van Rijk, PP | 1 |
| Hordijk, GJ; Koole, R; Stokkel, MP; ten Broek, FW; van Rijk, PP | 1 |
| Au, WY; Kwong, YL; Leung, G; Liang, R; Ma, SK; Ooi, GC; Shek, TW | 1 |
| Aigner, RM; Karpf, E; Schwarz, T; Wurzinger, G | 1 |
| Chisin, R; Larson, SM; Macapinlac, HA; Ramos, CD; Yeung, HW | 1 |
| Adams, S; Baum, RP; Kovács, AF; Stuckensen, T | 1 |
| Kitagawa, Y; Maruta, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Fukumitsu, H; Hoshikawa, T; Ishikawa, K; Makuuchi, H; Nasu, S; Sadahiro, S; Shibuya, M; Shimakura, Y; Suzuki, T; Tajima, T; Yasuda, S; Yazawa, N | 1 |
11 review(s) available for fluorodeoxyglucose f18 and Cancer, Second Primary
| Article | Year |
|---|---|
[
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms; Neoplasms, Second Primary; Positron-Emission Tomography; Radiologists; Radiopharmaceuticals; Spinal Cord | 2022 |
Metachronous Isolated Splenic Metastasis in a Young Patient With Renal Cell Carcinoma: Case Report and Literature Review.
Topics: Adult; Biopsy, Needle; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Laparoscopy; Male; Neoplasms, Second Primary; Nephrectomy; Positron Emission Tomography Computed Tomography; Risk Assessment; Splenectomy; Splenic Neoplasms; Time Factors; Treatment Outcome | 2019 |
Warthin's tumor of the larynx: a very rare case and systematic review of the literature.
Topics: Adenolymphoma; Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngoscopy; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
PET-associated incidental neoplasms of the thyroid.
Topics: Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Neoplasms; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Risk Factors; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Role of positron emission tomography (PET) in head and neck cancer.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Treatment Outcome | 2010 |
Hematopoietic tumors and metastases involving bone.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Hematologic Neoplasms; Histiocytosis, Langerhans-Cell; Humans; Leukemia; Lymphoma; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Testicular germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Fluorodeoxyglucose F18; Gene Expression Profiling; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Proteins; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Positron-Emission Tomography; Radiotherapy, Adjuvant; Risk Factors; Testicular Neoplasms; Treatment Outcome | 2006 |
Current status of FDG-PET for head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2008 |
18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
A case of duodenal involvement of multiple myeloma imaged by positron emission tomography with 18F-fluorodeoxyglucose.
Topics: Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Plasmacytoma; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2001 |
8 trial(s) available for fluorodeoxyglucose f18 and Cancer, Second Primary
| Article | Year |
|---|---|
Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated
Topics: Adult; Aged; Axitinib; Bevacizumab; Carcinoma, Renal Cell; Cell Proliferation; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Indazoles; Indoles; London; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Pyrimidines; Pyrroles; Sulfonamides; Sunitinib; Treatment Outcome | 2017 |
A feasibility study on adaptive
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cetuximab; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated | 2018 |
Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiation Injuries; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Vinblastine; Young Adult | 2014 |
Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Recurrence; Time Factors | 2009 |
¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.
Topics: Biological Transport; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
125 other study(ies) available for fluorodeoxyglucose f18 and Cancer, Second Primary
| Article | Year |
|---|---|
Whole-body hybrid positron emission tomography imaging yields clinically relevant information in the staging and restaging of sinonasal tumors.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Prognostic value of total metabolic tumour volume and therapy-response assessment by [
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Mitogen-Activated Protein Kinase Kinases; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Retrospective Studies; Tumor Burden | 2022 |
A Solitary Spinal Cord Metastasis From Lung Cancer Displayed on 18 F-FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms | 2022 |
Detecting Interval Distant Metastases With 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers.
Topics: Adult; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Melanin-Targeted PET Imaging With 18F-PFPN for Identifying Gastric Metastatic Melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Male; Melanins; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Stomach | 2022 |
Solitary Splenic Metastasis From Endometrial Carcinoma Revealed on FDG PET/CT.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Splenic Neoplasms | 2022 |
Adamantinoma-Like Ewing Sarcoma of the Mandible Evaluated on 18F-FDG PET/CT.
Topics: Adamantinoma; Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Male; Mandible; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Positron Emission Tomography Computed Tomography; Sarcoma, Ewing | 2022 |
Metastatic primary breast neuroendocrine neoplasms: a case series.
Topics: Adult; Breast Neoplasms; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Second Primary; Neuroendocrine Tumors; Prognosis; Retrospective Studies | 2023 |
Primary Aortic Epithelioid Angiosarcomas With Metastatic Disease Detected by 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Hemangiosarcoma; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Solitary Malignant Peripheral Nerve Sheath Tumor of Lumbar Vertebra Mimicking Metastatic Malignancy.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Neoplasms; Neoplasms, Second Primary; Nerve Sheath Neoplasms; Neurofibrosarcoma; Positron Emission Tomography Computed Tomography | 2023 |
Internal Thoracic Vein Tumor Thrombus From Sternal Melanoma Metastasis on 18 F-FDG PET/CT.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Metastasis; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Sternum; Thrombosis | 2023 |
Differentiation of Discordant Lesions on Dual-Tracer PET/CT (
Topics: Carcinoma, Hepatocellular; Cell Differentiation; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Neoplasms, Second Primary; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms | 2023 |
Bone Lipogranuloma Mimicking Metastatic Disease on 18F-FDG PET/CT.
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography | 2023 |
PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study.
Topics: Carcinoma, Neuroendocrine; Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2023 |
Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2020 |
Early Detection of Secondary Central Nervous System Lymphoma on PET/CT.
Topics: Central Nervous System Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography | 2020 |
Metastatic melanoma presenting as intravenous tumour thrombus.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thrombosis | 2020 |
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition.
Topics: Adult; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Progression-Free Survival; Radiopharmaceuticals; Tumor Burden; Young Adult | 2020 |
The concomitance of lymphoma and breast carcinoma in the bone.
Topics: Biomarkers, Tumor; Biopsy; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography | 2020 |
The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies | 2022 |
FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2021 |
Malignant somatic transformation arising from teratoma in metastatic testicular germ cell tumor detected on
Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Teratoma; Testicular Neoplasms | 2022 |
Lymphangiosarcoma of the hip arising in a congenital non-irradiated lymphangioma.
Topics: Adult; Biopsy; Cell Transformation, Neoplastic; Fatal Outcome; Female; Fluorodeoxyglucose F18; Hip; Humans; Lymphangioma; Lymphangiosarcoma; Neoplasms, Second Primary; Positron-Emission Tomography; Retroperitoneal Neoplasms; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2017 |
PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Neoplasms, Second Primary; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2018 |
[Inflammatory Pulmonary Myofibroblast Tumor Suspected of Pulmonary Metastasis of the Lung Cancer;Report of a Case].
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Myofibroblasts; Myofibroma; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2018 |
18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab.
Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Ipilimumab; Longitudinal Studies; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Treatment Outcome; Vemurafenib | 2019 |
Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images.
Topics: Adenocarcinoma of Lung; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Organometallic Compounds; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2019 |
Diagnostic value of surveillance
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Second Primary; Recurrence; Retrospective Studies; Treatment Outcome | 2019 |
Concomitant Prostate Carcinoma and Follicular Lymphoma: "Flip-Flop" Appearances on PSMA and FDG PET/CT Scans.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lysine; Male; Neoplasm Metastasis; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea | 2019 |
Clinicopathologic characteristics of synchronous primary thyroid cancer detected by initial staging 18F-FDG PET-CT examination in patients with underlying malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Child; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A; Young Adult | 2013 |
PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient.
Topics: Adult; Aged; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis; Tomography, X-Ray Computed | 2013 |
Repetition of FDG PET study in the same day after appropriate patient preparation revealed two new cancer localizations: a case report.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Time Factors; Urinary Bladder Neoplasms | 2013 |
Synchronous metastatic pulmonary adenocarcinoma with small cell lymphoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography | 2014 |
Solitary breast metastasis from recurrent gallbladder carcinoma simulating a second primary on 18F-FDG PET/CT.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
(18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Young Adult | 2013 |
Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDG.
Topics: Cell Dedifferentiation; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Chromosome Aberrations; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin Heavy Chains; Immunophenotyping; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Male; Middle Aged; Mutation; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Young Adult | 2014 |
A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Topics: Adenocarcinoma, Follicular; Age Factors; Aged; Algorithms; Biomarkers, Tumor; Biopsy, Fine-Needle; Diagnosis, Differential; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Risk Adjustment; Risk Factors; Sensitivity and Specificity; Sex Factors; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2014 |
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Young Adult | 2014 |
Clinical significance of incidental findings on staging positron emission tomography for oesophagogastric malignancies.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2014 |
Malignant peritoneal mesothelioma with lower extremity metastasis: PET/CT imaging.
Topics: Aged; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Lower Extremity; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Neoplasms, Second Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Interpretation of suspect head and neck fixations seen on PET/CT in lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Should We Routinely Investigate Incidental Head and Neck Findings on 18-Fluorodeoxyglucose Positron Emission Tomography in Patients Being Staged for Non-small Cell Lung Cancer? A Retrospective Analysis.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2015 |
Positron emission tomography combined with computed tomography for diagnosis of synchronous tumors.
Topics: Aged; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Prognostic Significance of the Standardized Uptake Value on Positron Emission Tomography in Patients with Multiple Clinical-N0 Lung Cancers.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2015 |
Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed | 2015 |
Impact of incidental findings on integrated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in patients with gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Detection of subclinical recurrence or second primary cancer using (18) F-FDG PET/CT in patients treated curatively for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2016 |
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prednisone; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2016 |
A 79-Year-Old Man With Interstitial Lung Disease and Cryptic Area of High 18 Fluorodeoxyglucose Uptake in Left Upper Lobe.
Topics: Adenocarcinoma; Aged; Carcinoembryonic Antigen; Colectomy; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Monitoring, Physiologic; Neoplasms, Second Primary; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
Topics: Aged; Aged, 80 and over; Biological Transport; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms | 2016 |
Conjunctival Melanoma on 18F-FDG PET/CT as a Second Primary Cancer.
Topics: Conjunctival Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
[(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Second Primary; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Unusual Presentation of Elastofibroma Dorsi on 18F-FDG-PET/CT: A Case Report.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Fibrous Tissue; Neoplasms, Second Primary; Pleural Effusion; Positron-Emission Tomography; Thoracic Neoplasms | 2016 |
Clinicopathological Features of Second Primary Colorectal Cancer Incidentally Identified by 18F-FDG-PET.
Topics: Aged; Asymptomatic Diseases; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2015 |
FDG PET/CT Imaging of Prostate Carcinosarcoma.
Topics: Carcinoma, Squamous Cell; Carcinosarcoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Transurethral Resection of Prostate; Urinary Retention | 2016 |
Synchronous or metachronous lymphoma and metastatic cutaneous squamous cell carcinoma in the head and neck region: a diagnostic and management dilemma.
Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography | 2016 |
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Kallikreins; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Soft Tissue Neoplasms | 2016 |
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Cohort Studies; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Rectal Neoplasms; Risk Assessment; Statistics, Nonparametric; Survival Analysis | 2017 |
Intensity of FDG uptake is not everything: synchronous liposarcoma and fibrous dysplasia in the same patient on FDG PET-CT imaging.
Topics: Diagnostic Imaging; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liposarcoma; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Humerus; Lung Neoplasms; Male; Mesothelioma; Neoplasm Metastasis; Neoplasms, Second Primary; Osteitis Deformans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Cervical cancer coexisting with small lymphocytic lymphoma detected during positron emission tomography/computed tomography simulation: a case report.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging | 2008 |
FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Unsuspected second malignancy detection by FDG PET scan.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography | 2008 |
[Role of FDG PET-CT in cutaneous melanoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2008 |
Unexpected slight fluorodeoxyglucose-uptake on positron emission tomography in a pulmonary hamartoma.
Topics: Bronchial Neoplasms; Carcinoid Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Hamartoma; Humans; Lung Neoplasms; Male; Metaplasia; Middle Aged; Neoplasms, Second Primary; Ossification, Heterotopic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neoplasms, Squamous Cell; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
[Case of a sigmoid colon cancer with metachronous metastases of the stomach and the abdominal wall].
Topics: Abdominal Neoplasms; Adenocarcinoma; Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sigmoid Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
(18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Incidental PET/CT findings in the cancer patient: how should they be managed?
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pancreatectomy; Pancreatic Neoplasms; Pancreaticoduodenectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2010 |
[PET-CT in evaluation of pulmonary nodule--case report].
Topics: Adenocarcinoma, Clear Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Remnant pancreatectomy for recurrent or metachronous pancreatic carcinoma detected by FDG-PET: two case reports.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Second Primary; Pancreatectomy; Pancreatic Neoplasms; Radionuclide Imaging | 2010 |
The clinical significance of 18F-FDG-PET/CT in early detection of second primary malignancy in cancer patients.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Case report. PET/CT appearance of desmoid tumour of the chest wall.
Topics: Aged; Biopsy; Diagnosis, Differential; Female; Fibromatosis, Aggressive; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Wall | 2010 |
The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Blood Glucose; Cecal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.
Topics: Aged; Aged, 80 and over; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiography, Thoracic; Retrospective Studies; ROC Curve | 2010 |
Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Interesting image. Unsuspected synchronous thyroid carcinoma revealed on a post-therapy F-18 FDG PET/CT, in a patient with follicular lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Follicular; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Incidental carcinomas detected by PET/CT scans in patients with malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Lymphoma; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2010 |
Role of PET/CT screening in detecting a second primary carcinoma in patients with malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2011 |
Clinical value of FDG-PET for preoperative evaluation of endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Preoperative Period; Retrospective Studies | 2011 |
Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Postoperative Period; Tomography, X-Ray Computed; Young Adult | 2011 |
Synchronous second primary neoplasms detected by initial staging F-18 FDG PET/CT examination in patients with non-Hodgkin lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
The role of integrated F-18-FDG-PET scanning in the detection of M1 disease in oesophageal adenocarcinoma and impact on clinical management.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Colonic Neoplasms; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity | 2011 |
FDG-PET/CT in the diagnosis of recurrent breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Tumor-to-tumor metastasis: lung adenocarcinoma metastasizing to vestibular schwannoma suspected on preoperative [18F]-fluorodeoxyglucose positron emission tomography imaging.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Second Primary; Neuroma, Acoustic; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals | 2012 |
The management impact of clinically significant incidental lesions detected on staging FDG PET-CT in patients with non-small cell lung cancer (NSCLC): an analysis of 649 cases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Esophageal gastrointestinal stromal tumor: report of 7 patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Combined Modality Therapy; Electronic Health Records; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasms, Second Primary; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Hürthle cell neoplasms: a new differential diagnosis for 18F-FDOPA-avid thyroid nodules?
Topics: Adenoma, Oxyphilic; Adrenal Gland Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Second Primary; Pheochromocytoma; Positron-Emission Tomography; Thyroid Neoplasms; Thyroid Nodule | 2013 |
Enchondroma: a benign osseous lesion with high F-18 FDG uptake.
Topics: Adult; Chondroma; Chondrosarcoma; Diagnosis, Differential; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Hyalin; Melanoma; Neoplasm Staging; Neoplasms, Second Primary; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Diagnosis of a contralateral second testicular carcinoma by F18-FDG PET.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Second Primary; Testicular Neoplasms; Testis; Tomography, Emission-Computed | 2003 |
Positron emission tomography in cancer of the head and neck.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Importance of adrenal incidentaloma in patients with a history of malignancy.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Neoplasms, Second Primary; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Second Primary; Nose Neoplasms; Orbital Neoplasms; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed; Whole Body Imaging | 2006 |
Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Mastectomy, Segmental; Mediastinal Neoplasms; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Unsuspected FDG-PET findings in the follow-up of patients with lymphoma.
Topics: Aged; Biopsy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Infections; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Recurrence; Retrospective Studies | 2007 |
PET in face and neck tumours.
Topics: Facial Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
18F-fluorodeoxyglucose-avid thyroid incidentalomas in patients with lymphoma.
Topics: Biopsy, Fine-Needle; Carcinoma, Papillary; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2006 |
[Evaluation of efficacy and clinical impact of FDG-PET on patients with suspicion of recurrent cutaneous melanoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case Management; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Unnecessary Procedures | 2006 |
Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Incidental Findings; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
F-18 FDG-avid sclerosing angiomatoid nodular transformation (SANT) of the spleen: case study and literature review.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Hypertension; Legg-Calve-Perthes Disease; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Skin Neoplasms; Splenectomy; Splenic Neoplasms; Tomography, X-Ray Computed | 2007 |
Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphoma, B-Cell; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Oncocytic schneiderian papilloma confined to the sphenoid sinus detected by FDG-PET.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Second Primary; Oxyphil Cells; Papilloma; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sphenoid Sinus | 2007 |
Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Choroid Neoplasms; Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Injections, Intravenous; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Radiopharmaceuticals; Retrospective Studies; Sigmoid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2007 |
Detection of unsuspected metachronous second primary malignancy giving rise to supposed "non-iodine avid metastasis" in differentiated thyroid carcinoma.
Topics: Aged; Carcinoma, Papillary; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Middle Aged; Neoplasms, Second Primary; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2007 |
Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.
Topics: Adolescent; Adult; Aged; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Hodgkin lymphoma: Response assessment by revised International Workshop Criteria.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; International Cooperation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Accurate grading of 3 synchronous liposarcomas assessed by PET-CT in a single patient.
Topics: Biomarkers, Tumor; Cell Transformation, Neoplastic; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liposarcoma; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Tomography, X-Ray Computed | 2007 |
Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Multiple and incidentally found cancers detected by 18F-FDG positron emission tomography/CT at one examination.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
[Detection of multi-focal breast carcinoma using 2[18F] fluoro-deoxy-D-glucose positron emission tomography (FDG-PET)].
Topics: Adult; Blood Glucose; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Deoxyglucose; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Glycolysis; Humans; Neoplasm Staging; Neoplasms, Second Primary; Tomography, Emission-Computed | 1996 |
FDG PET in head and neck cancer.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Radiopharmaceuticals; Salivary Gland Neoplasms; Tomography, Emission-Computed | 1997 |
Laryngeal radionecrosis versus recurrent cancer: a clinical approach.
Topics: Algorithms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prospective Studies; Radiation Injuries; Radiotherapy; Tomography, Emission-Computed | 1998 |
Incidental second primary in the breast detected by F-18 FDG positron emission tomography scan.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Second Primary; Radiopharmaceuticals; Teratoma; Tomography, Emission-Computed | 1998 |
Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
Topics: Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Myeloblastoma (chloroma) in leukemia: case 2. Meningeal granulocytic sarcoma (chloroma) in essential thrombocythemia.
Topics: Antineoplastic Agents, Alkylating; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid; Melphalan; Meningeal Neoplasms; Middle Aged; Neoplasms, Second Primary; Thrombocytosis; Tomography, Emission-Computed | 2000 |
Detection of unsuspected gastric MALT-lymphoma with F-18-FDG-PET.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasms, Second Primary; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2000 |
Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Radiopharmaceuticals; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neoplasms, Second Primary; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |